(PharmaNewsWire.Com, November 29, 2017 ) The Middle East and Africa Radioimmunoassay Market was worth USD 33.21 million in 2016 and estimated to be growing at a CAGR of 3.18%, to reach USD 38.84 million by 2021. Radioimmunoassay (RIA) is an in-vitro assay technique that is used to measure the concentration of antigens in the blood. RIA encompasses the separation of protein from a mixture by using the specificity of antibody-antigen binding and their quantitation by using radioactivity.
Radioimmunoassay is used primarily in the healthcare industry due to its high sensitivity, which can be used to analyze nanomolar and picomolar concentrations of hormones in biological fluids. RIA has ever since becoming one of the major tools in various clinical laboratories for diagnostic procedures, such as assessing the plasma levels of most of the hormones, identifying the presence of certain abused drugs, checking for the presence of hepatitis B surface antigen in donated blood, and other similar applications. This technique has also proven to be useful in the early detection of cancer, treatment of peptic ulcers, research with neurotransmitters, detection of infections, and identification of allergens in food and house dust, and more applications for the same are being researched all the time.
The major factors affecting the Middle East and Africa Radioimmunoassay Market include the high investment, the increasing emphasis on R&D in the sector, technological advancements, their increased usage in pharmaceutical industries, research, rising need for quality and error-free diagnosis and consumer awareness. However, in spite of the drivers, the market remains restrained by the high costs associated with its usage, and the stern regulatory restriction and expertise required for the analysis.
The Middle East and Africa Radioimmunoassay Market is broadly classified into Reagents and Kits Market and Analyzers Market based on type, based on End User into Hospital, Pharmaceutical Industry and CRO, Academics and Clinical Diagnostic Laboratories, on the basis of Application into Research and Clinical Diagnostics. Based on geography, the Middle-East & Africa market is analyzed under regions of Middle-East and Africa. The major countries in the region are UAE, Saudi Arabia, Qatar, Egypt and South Africa. The region is the smallest market globally with a growth rate that is also below average.
The Middle East and Africa Radioimmunoassay Market is highly competitive with a large number of players. Key market players dominating the market with their products and services are: 1) DIA source Immuno Assays SA 2) Beckman Coulter Inc 3) IBL International 4) PerkinElmer Inc 5) DRG International Inc 6) MP Biomedicals LLC 7) Cisbio 8) Euro Diagnostica AB 9) DiaSorin S.p.A 10) EMD Millipore 11) Izotop 12) Berthold Technologies GmbH & Co. KG 13) Stratec Biomedical AG.
Market Segmentation: 1) Type 2) End User 3) Application
About us: Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialties with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
